Does Famotidine Reduce the Risk of Progression to Severe Disease, Death, and Intubation for COVID-19 Patients? A Systemic Review and Meta-Analysis

ConclusionFamotidine has no significant protective effect in reducing the risk of developing serious illness, death, and intubation for COVID-19 patients. More original studies are needed to further clarify whether it is associated with reduced risk of the severity, death, and intubation for COVID-19 patients.

http://link.springer.com/10.1007/s10620-021-06872-z

Source: Digestive Diseases and Sciences - February 24, 2021 Category: Gastroenterology Source Type: research